These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12619156)

  • 1. RxFISH karyotype and MYC amplification in the HT-29 colon adenocarcinoma cell line.
    Corzo C; Petzold M; Mayol X; Espinet B; Salido M; Serrano S; Real FX; Solé F
    Genes Chromosomes Cancer; 2003 Apr; 36(4):425-6. PubMed ID: 12619156
    [No Abstract]   [Full Text] [Related]  

  • 2. N-myc amplification was rarely detected by fluorescence in situ hybridization in retinoblastoma.
    Kim JH; Choi JM; Yu YS; Kim DH; Kim JH; Kim KW
    Hum Pathol; 2008 Aug; 39(8):1172-5. PubMed ID: 18538370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of a serous papillary adenocarcinoma cell line of the human ovary in a serum-free culture.
    Emoto M; Oshima K; Ishiguro M; Iwasaki H; Kawarabayashi T; Kikuchi M
    Pathol Res Pract; 1999; 195(4):237-42. PubMed ID: 10337661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double minutes (dmin) and homogeneously staining regions (hsr) in myeloid disorders: a new case suggesting that dmin form hsr in vivo.
    Reddy KS
    Cytogenet Genome Res; 2007; 119(1-2):53-9. PubMed ID: 18160782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fish detected p53 deletion and N-MYC amplification in colorectal cancer.
    Ozakyol A; Ozdemir M; Artan S
    Hepatogastroenterology; 2006; 53(68):192-5. PubMed ID: 16608022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene amplification of Myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinoma.
    Ooi A; Suzuki S; Nakazawa K; Itakura J; Imoto I; Nakamura H; Dobashi Y
    Anticancer Res; 2009 Jan; 29(1):19-26. PubMed ID: 19331129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aneuploidy of chromosome 8 and C-MYC amplification in individuals from northern Brazil with gastric adenocarcinoma.
    Calcagno DQ; Leal MF; Taken SS; Assumpção PP; Demachki S; Smith Mde A; Burbano RR
    Anticancer Res; 2005; 25(6B):4069-74. PubMed ID: 16309200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYC amplification and TERT expression in breast tumor progression.
    Bodvarsdóttir SK; Steinarsdóttir M; Hilmarsdóttir H; Jónasson JG; Eyfjörd JE
    Cancer Genet Cytogenet; 2007 Jul; 176(2):93-9. PubMed ID: 17656250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two populations of double minute chromosomes harbor distinct amplicons, the MYC locus at 8q24.2 and a 0.43-Mb region at 14q24.1, in the SW613-S human carcinoma cell line.
    Guillaud-Bataille M; Brison O; Danglot G; Lavialle C; Raynal B; Lazar V; Dessen P; Bernheim A
    Cytogenet Genome Res; 2009; 124(1):1-11. PubMed ID: 19372663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct nuclear arrangement of active and inactive c-myc genes in control and differentiated colon carcinoma cells.
    Harnicarová A; Kozubek S; Pacherník J; Krejci J; Bártová E
    Exp Cell Res; 2006 Dec; 312(20):4019-35. PubMed ID: 17046748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precise breakpoint characterization of the colon adenocarcinoma cell line HT-29 clone 19A by means of 24-color fluorescence in situ hybridization and multicolor banding.
    Kuechler A; Weise A; Michel S; Schaeferhenrich A; Pool-Zobel BL; Claussen U; Liehr T
    Genes Chromosomes Cancer; 2003 Feb; 36(2):207-10. PubMed ID: 12508250
    [No Abstract]   [Full Text] [Related]  

  • 12. Trisomy 4 associated with double minute chromosomes and MYC amplification in acute myeloblastic leukemia.
    Receveur A; Ong J; Merlin L; Azgui Z; Merle-Béral H; Berger R; Nguyen-Khac F
    Ann Genet; 2004; 47(4):423-7. PubMed ID: 15581842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the cryptic interstitial deletion of 8q24 surrounding MYC a common mechanism in the formation of double minute chromosome?
    Christacos NC; Sherman L; Roy A; DeAngelo DJ; Dal Cin P
    Cancer Genet Cytogenet; 2005 Aug; 161(1):90-2. PubMed ID: 16080965
    [No Abstract]   [Full Text] [Related]  

  • 14. Murine pancreatic tumor cell line TD2 bears the characteristic pattern of genetic changes with two independently amplified gene loci.
    Schreiner B; Greten FR; Baur DM; Fingerle AA; Zechner U; Böhm C; Schmid M; Hameister H; Schmid RM
    Oncogene; 2003 Oct; 22(43):6802-9. PubMed ID: 14555993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined spectral karyotyping, multicolor banding, and microarray comparative genomic hybridization analysis provides a detailed characterization of complex structural chromosomal rearrangements associated with gene amplification in the osteosarcoma cell line MG-63.
    Lim G; Karaskova J; Vukovic B; Bayani J; Beheshti B; Bernardini M; Squire JA; Zielenska M
    Cancer Genet Cytogenet; 2004 Sep; 153(2):158-64. PubMed ID: 15350306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous pattern of chromosomal breakpoints involving the MYC locus in multiple myeloma.
    Fabris S; Storlazzi CT; Baldini L; Nobili L; Lombardi L; Maiolo AT; Rocchi M; Neri A
    Genes Chromosomes Cancer; 2003 Jul; 37(3):261-9. PubMed ID: 12759924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human Burkitt's lymphoma cell line carrying t(8;22) and t(14;18) translocations.
    Kiefer T; Schüler F; Knopp A; Wimmer M; Hirt C; Schaefer HE; Dölken G
    Ann Hematol; 2007 Nov; 86(11):821-30. PubMed ID: 17622530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic, spectral karyotyping, fluorescence in situ hybridization, and comparative genomic hybridization characterization of two new secondary leukemia cell lines with 5q deletions, and MYC and MLL amplification.
    Knutsen T; Pack S; Petropavlovskaja M; Padilla-Nash H; Knight C; Mickley LA; Ried T; Elwood PC; Roberts SJ
    Genes Chromosomes Cancer; 2003 Jul; 37(3):270-81. PubMed ID: 12759925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.
    Robanus-Maandag EC; Bosch CA; Kristel PM; Hart AA; Faneyte IF; Nederlof PM; Peterse JL; van de Vijver MJ
    J Pathol; 2003 Sep; 201(1):75-82. PubMed ID: 12950019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.
    Martín-Subero JI; Odero MD; Hernandez R; Cigudosa JC; Agirre X; Saez B; Sanz-García E; Ardanaz MT; Novo FJ; Gascoyne RD; Calasanz MJ; Siebert R
    Genes Chromosomes Cancer; 2005 Aug; 43(4):414-23. PubMed ID: 15852472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.